Working with other Genomic Medicine Stakeholders and Patients
The SWGLH works day-to-day with the Genomics Unit in NHS England and NHS Improvement, and with key clinical services, patient groups and other partners to ensure that genomic laboratory services ae aligned with national policy and with the needs of the SW population.
Our main NHS partners are the 11 Trusts that provide acute care for the SW England population of about 5 million people:
- Northern Devon Healthcare NHST
- Plymouth Hospitals NHST
- Royal Cornwall Hospitals NHST
- Royal Devon and Exeter NHSFT
- Torbay and South Devon NHSFT
- Gloucestershire Hospitals NHSFT
- North Bristol NHS
- Taunton and Somerset NHSFT
- University Hospitals Bristol NHSFT
- Yeovil District Hospital NHSFTRoyal United Hospitals Bath NHSFT
Oversight and governance of the SWGLH is currently provided by a Partnership Board which meets regularly and is accountable to an oversight board consisting of the CEOs of the 11 acute SW NHS Trusts.
The membership of the Partnership Board comprises senior members of the SWGLH leadership, the leads of the two regional Clinical Genetic services and representatives from key health service organisations, Partner Trusts and a patient and public group:
- Independent Chair
- SWGLH Operations Director
- SWGLH Scientific Director
- SWGLH Medical Director
- SWGLH Informatics Lead
- Clinical Genetics Lead, University Hospitals Bristol and Weston
- Clinical Genetics Lead, Royal Devon and Exeter Hospital
- Cancer Alliance representative
- Academic Health Science Network representative
- Pathology network representative
- West of England and South West Genomic Medicine Centre directors
- Patient and Public representatives
- Primary care representative
- Senior commissioning representative
- Senior management representative from main stakeholder NHS Trusts
This oversight structure is expected to transition to represent the SW Genomic Medicine Alliance in mid 2021